Medicare Enrolled
Dr. Christopher Alexander, DO
Hematology · Ormond Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alexander from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alexander?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alexander
Dr. Christopher Alexander is a hematology specialist in Ormond Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Alexander performed 156,871 Medicare services across 4,388 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alexander received a total of $10,828 from 78 pharmaceutical and/or device companies across 589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alexander is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in FL
$10,828 industry payments
Medicare Practice Summary
Medicare Utilization ↗156,871
Medicare services
Top 33% in FL for hematology
4,388
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,256 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 64,770 | $0 | $4 |
| Iron infusion (Injectafer) | 18,750 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 13,180 | $6 | $23 |
| Pembrolizumab injection (Keytruda) | 11,400 | $42 | $137 |
| Denosumab injection (Prolia/Xgeva) | 11,280 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 10,400 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 7,620 | $0 | $2 |
| Complete blood count (CBC) with differential | 2,974 | $8 | $29 |
| Blood draw (venipuncture) | 2,899 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,640 | $0 | $3 |
| Iron infusion (Monoferric) | 2,200 | $17 | $57 |
| Office visit, established patient (30-39 min) | 1,186 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,120 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 968 | $0 | $9 |
| Drug injection, under skin or into muscle | 800 | $10 | $69 |
| Injection of additional new drug or substance into vein | 487 | $12 | $61 |
| Office visit, established patient (20-29 min) | 434 | $62 | $239 |
| Administration of chemotherapy into vein, 1 hour or less | 415 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 348 | $47 | $189 |
| Hospital follow-up visit, moderate complexity | 224 | $62 | $197 |
| Injection, magnesium sulfate, per 500 mg | 214 | $1 | $2 |
| Injection, carboplatin, 50 mg | 210 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 203 | $21 | $84 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 202 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 199 | $15 | $56 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 159 | $16 | $59 |
| Injection, diphenhydramine hcl, up to 50 mg | 155 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 149 | $21 | $79 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 145 | $3 | $11 |
| Injection of drug or substance into vein | 139 | $27 | $156 |
| Prothrombin time test (blood clotting) | 113 | $4 | $15 |
| Administration of additional new drug or substance into vein, 1 hour or less | 91 | $49 | $178 |
| New patient office visit (45-59 min) | 89 | $116 | $452 |
| Initial hospital admission, high complexity | 85 | $137 | $556 |
| Injection, zoledronic acid, 1 mg | 82 | $7 | $69 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 81 | $138 | $562 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 71 | $25 | $89 |
| Red blood count, automated test | 68 | $4 | $10 |
| Automated urinalysis | 65 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 58 | $136 | $474 |
| Administration of additional new drug or substance into vein using push technique | 53 | $41 | $170 |
| Infusion, normal saline solution , 1000 cc | 52 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 34 | $9 | $42 |
| Infusion into a vein for hydration, 31-60 minutes | 32 | $24 | $156 |
| Drawing of blood for a medical problem | 16 | $58 | $277 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 11 | $1 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
55.2% high complexity
39.3% medium
5.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,828
Total received (2018-2024)
Avg $1,547/year across 7 years
Top 40% in FL for hematology
78
Companies
589
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,476 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$352 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,591
2023
$2,129
2022
$1,646
2021
$240
2020
$236
2019
$1,618
2018
$2,369
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,341
E.R. Squibb & Sons, L.L.C.
$609
PFIZER INC.
$603
Genentech USA, Inc.
$550
Janssen Biotech, Inc.
$547
Nevro Corp.
$447
Amgen Inc.
$377
Astellas Pharma US Inc
$360
Incyte Corporation
$315
Merck Sharp & Dohme Corporation
$303
AstraZeneca Pharmaceuticals LP
$296
Lilly USA, LLC
$246
GlaxoSmithKline, LLC.
$213
Pharmacyclics LLC, An AbbVie Company
$204
Ipsen Biopharmaceuticals, Inc
$202
Kite Pharma, Inc.
$181
SANOFI-AVENTIS U.S. LLC
$180
Eisai Inc.
$172
Gilead Sciences, Inc.
$172
Takeda Pharmaceuticals U.S.A., Inc.
$171
ABBVIE INC.
$159
Regeneron Healthcare Solutions, Inc.
$157
Celgene Corporation
$155
TerSera Therapeutics LLC
$154
Bayer HealthCare Pharmaceuticals Inc.
$151
GENZYME CORPORATION
$148
Abbott Laboratories
$140
Merck Sharp & Dohme LLC
$134
Seagen Inc.
$112
EMD Serono, Inc.
$106
Alexion Pharmaceuticals, Inc.
$104
Rigel Pharmaceuticals, Inc.
$93
ARRAY BIOPHARMA INC
$87
Mirati Therapeutics, Inc.
$85
Exelixis Inc.
$84
SOBI, INC
$79
Pharmacosmos Therapeutics Inc.
$78
JAZZ PHARMACEUTICALS INC.
$77
AbbVie Inc.
$75
SERVIER PHARMACEUTICALS LLC
$71
Daiichi Sankyo Inc.
$68
Seattle Genetics, Inc.
$64
MEDIVATION FIELD SOLUTIONS LLC
$59
Bayer Healthcare Pharmaceuticals Inc.
$48
Taiho Oncology, Inc.
$48
AVEO Pharmaceuticals, Inc.
$42
Acrotech Biopharma Inc.
$41
Stemline Therapeutics Inc.
$39
TESARO, Inc.
$38
EISAI INC.
$37
G1 Therapeutics, Inc.
$37
Karyopharm Therapeutics Inc.
$35
Octapharma USA, Inc.
$35
Alnylam Pharmaceuticals Inc.
$32
Aurobindo Pharma USA, Inc.
$32
Pharmacyclics LLC, an AbbVie Company
$30
Apellis Pharmaceuticals, Inc.
$29
Foundation Medicine, Inc.
$29
Horizon Therapeutics plc
$26
Janssen Pharmaceuticals, Inc
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Novocure Inc.
$23
Coherus Biosciences Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$22
ADC Therapeutics America, Inc.
$20
Clovis Oncology, Inc.
$19
Tolmar, Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$16
Agios Pharmaceuticals, Inc.
$16
CTI BioPharma Corp.
$14
Aveo Pharmaceuticals, Inc.
$14
Puma Biotechnology, Inc.
$14
TAIHO ONCOLOGY, INC.
$13
MACROGENICS, INC.
$13
Sysmex Inostics Inc
$13
NOVARTIS PHARMACEUTICALS CORPORATION
$12
Jazz Pharmaceuticals Inc.
$12
Myriad Genetic Laboratories, Inc.
$11
Top 3 companies account for 23.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · Alecensa · Aliqopa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · OPDIVO · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROCLAIM · PROMACTA · Padcev · Perjeta · Polivy · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANDOSTATIN LAR · SCEMBLIX · SOMATULINE DEPOT · SUTENT · SYLVANT · Senza Spinal Cord Stimulation System · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
8
Per 100K population
1.4
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Alexander is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Alexander experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Alexander performed 64,770 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alexander receive payments from pharmaceutical companies?
Yes. Dr. Alexander received a total of $10,828 from 78 companies across 589 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alexander's costs compare to other hematologists in Ormond Beach?
Dr. Alexander's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alexander) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Ormond Beach
Browse hematologists in Ormond Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology